Form 8-K - Current report:
SEC Accession No. 0001641172-25-015861
Filing Date
2025-06-20
Accepted
2025-06-20 16:30:28
Documents
14
Period of Report
2025-06-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43893
2 EX-99.1 ex99-1.htm EX-99.1 12608
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4489
  Complete submission text file 0001641172-25-015861.txt   231330

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20250617.xsd EX-101.SCH 3014
5 XBRL LABEL FILE aim-20250617_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE aim-20250617_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3566
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 251061847
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)